ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
2,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
3,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
3,2,Renal colic,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
4,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
4,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
4,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
5,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
6,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
7,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
8,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
9,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
9,4,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
9,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
10,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11,1,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
12,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
12,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
12,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
12,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
12,5,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
12,6,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
12,7,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
13,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
14,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
15,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
16,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
17,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
17,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
18,1,Blood iron increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
18,2,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
18,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
19,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
19,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
19,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
19,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
19,5,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
19,6,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
19,7,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
19,8,High density lipoprotein decreased,Cholesterol analyses,Lipid analyses,Inv,N
19,9,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
19,10,Monocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
19,11,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
19,12,Red cell distribution width increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
19,13,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
19,14,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
20,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
20,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
20,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
20,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
20,5,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
20,6,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
21,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
22,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
23,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
24,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
25,1,Acne,Acnes,Skin appendage conditions,Skin,N
25,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
25,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
25,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
26,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
26,2,Bruxism,Stereotypies and automatisms,Changes in physical activity,Psych,N
26,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
26,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
26,5,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
26,6,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
26,7,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
27,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
28,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
28,2,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
28,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
28,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
28,5,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
28,6,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
28,7,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
28,8,Postictal state,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
29,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
30,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
31,1,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
31,2,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
32,1,Metal poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
32,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
33,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
33,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
33,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
34,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
35,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
36,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
